STOCK TITAN

Cellebrite Di Ltd Stock Price, News & Analysis

CLBT Nasdaq

Welcome to our dedicated page for Cellebrite Di news (Ticker: CLBT), a resource for investors and traders seeking the latest updates and insights on Cellebrite Di stock.

Cellebrite DI Ltd. (NASDAQ: CLBT) generates a steady flow of news related to digital investigations, AI-powered analytics and public safety technology. As a global provider of digital investigative and intelligence solutions for public safety organizations, intelligence agencies, defense organizations and enterprises, the company frequently issues updates on its software platform, strategic initiatives and regulatory milestones.

News about Cellebrite often covers product and platform innovation, including releases that expand its Digital Investigation Platform. Recent announcements have highlighted enhancements to its flagship digital forensics solution, Inseyets, the expanded and reimagined Guardian suite for investigations and analytics, and the introduction of Guardian Investigate, a SaaS-based investigative solution that uses agentic AI to analyze multiple evidence types. Updates also describe new deployment options such as AWS GovCloud for Pathfinder and developments in the Cellebrite Government Cloud.

Investors and practitioners following CLBT news will also see corporate and strategic developments, such as the agreement and subsequent completion of the Corellium acquisition, which adds Arm-based mobile virtualization capabilities for security research and testing. Other coverage includes leadership changes, like the appointment of a new chief executive officer and chief financial officer, and governance events such as shareholder meeting outcomes.

Cellebrite’s news flow additionally features public sector and compliance milestones, including progress toward FedRAMP High authorization for its government cloud environment with sponsorship from the U.S. Department of Justice, and partnerships that support investigations into crimes against children. For ongoing insight into how Cellebrite’s technology, customer relationships and regulatory posture evolve, readers can review this CLBT news page regularly for the latest press releases and official updates.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.3%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.56%
Tags
conferences
-
Rhea-AI Summary

Cellebrite DI Ltd. (Nasdaq: CLBT) announced the appointment of Mark Fitzsimons as Managing Director for its Asia-Pacific (APAC) operations, effective April 17, 2023. Based in Singapore, Fitzsimons brings over 25 years of B2B enterprise software sales and strategy experience, having previously worked with companies like Everise and Software AG.

The company's CEO, Yossi Carmil, emphasized Fitzsimons' expertise as critical for Cellebrite's growth in APAC, particularly in addressing law enforcement's digital investigation needs. Fitzsimons aims to enhance the company's mission by delivering exceptional digital intelligence solutions across the region.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.3%
Tags
none
Rhea-AI Summary

Cellebrite (NASDAQ: CLBT) will announce its first-quarter 2023 financial results on May 10, 2023, before the market opens. Following the release, the company will host a live conference call at 8:30 a.m. ET to review the results and discuss its full-year outlook. Investors can access the call via phone at 203-518-9814 or through a live webcast. Historical financial data will also be made available on the company’s investor relations website. Cellebrite specializes in Digital Intelligence solutions, aimed at enhancing legal investigations and safeguarding community privacy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.72%
Tags
-
Rhea-AI Summary

Cellebrite has been awarded the 2022 North American Customer Value Leadership Award by Frost & Sullivan, recognizing the company's expertise in Digital Intelligence (DI) solutions. With over 60,000 product licenses across 130 countries, Cellebrite aims to enhance customer operations and digital forensic intelligence. CEO Yossi Carmil emphasized the company's commitment to addressing customer needs in the evolving DI landscape. The company offers innovative solutions, including a cloud-based evidence management system and an open-source intelligence product, enhancing investigation efficiency. Frost & Sullivan noted Cellebrite's focus on improving customer ROI and retention through exceptional service and technology. This award highlights Cellebrite’s role as a leader in the DI sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.89%
Tags
none
-
Rhea-AI Summary

Cellebrite has launched Pathfinder X, an advanced AI-enabled investigative analytics solution designed to enhance digital investigations. The software features cloud deployment through AWS and Azure, a hub and spoke deployment format for dispersed teams, and robust user management for security compliance. Pathfinder X improves data mapping and helps identify persons of interest from various data sources, streamlining investigations. The technology has already shown effectiveness in ongoing cases, including a recent investigation by the Lake Jackson Police Department. Notably, Cellebrite secured substantial contracts valued over $10 million with European and Australian police forces.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.51%
Tags
none
Rhea-AI Summary

Cellebrite DI Ltd. (Nasdaq: CLBT) recently announced the integration of its LegalView Physical Analyzer with RelativityOne, aimed at enhancing the efficiency of corporate investigations. Scheduled for release in spring 2023, this add-on simplifies data collection and review from multiple mobile devices, addressing the growing demand for swift mobile data handling in legal contexts. Chris Brown from Relativity highlighted the integration's potential to optimize evidence management, while Ken Basore of Cellebrite emphasized its role in conserving resources and improving workflows for legal investigators. This collaboration is set to be showcased at Legalweek from March 20-23, 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.38%
Tags
none
-
Rhea-AI Summary

Cellebrite reported a strong financial performance for Q4 and the full year 2022, with Annual Recurring Revenue (ARR) reaching $249 million, up 33% year-over-year. Q4 revenue was $74 million, representing a 9% increase year-over-year, with subscription revenue at $62.3 million, up 24%. The company's recurring revenue retention rate stood at 130%. Adjusted EBITDA for Q4 was $16.1 million, achieving a 21.8% margin. For 2023, Cellebrite expects ARR to be between $300-$310 million and total revenue between $305-$315 million, indicating continued growth potential.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.9%
Tags
-
Rhea-AI Summary

Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in Digital Intelligence solutions, announced a significant collaboration in Brazil with The Exodus Road, an anti-human trafficking nonprofit. In 2022, their joint efforts with Brazilian law enforcement resulted in nine operations that directly freed 152 trafficking survivors and led to the arrest of 20 traffickers. Cellebrite provided crucial funding and technology support to enhance the effectiveness of these operations. Both organizations emphasize the ongoing need to combat human trafficking, with Cellebrite committed to ongoing support and training for law enforcement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.51%
Tags
none
Rhea-AI Summary

Cellebrite, a digital intelligence leader, revealed in a recent study that hybrid work is complicating data collection for eDiscovery professionals, hindering investigations into corporate fraud, IP theft, and sexual harassment. Key findings from 550 professionals in 45 countries include that 70% cite offsite mobile device access as a major challenge, 63% mention difficulties with messaging apps like WhatsApp, and 56% face issues accessing remote employee data. To address these challenges, Cellebrite's Endpoint Inspector offers targeted data collection solutions, enabling efficient handling of digital evidence across various platforms.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.42%
Tags
none

FAQ

What is the current stock price of Cellebrite Di (CLBT)?

The current stock price of Cellebrite Di (CLBT) is $11.03 as of April 10, 2026.

What is the market cap of Cellebrite Di (CLBT)?

The market cap of Cellebrite Di (CLBT) is approximately 3.1B.